Zoltero 4 mg (Zoledronic Acid Injection) contains Zoledronic Acid, a potent third-generation bisphosphonate that works by inhibiting osteoclast-mediated bone resorption. It is widely used in oncology to protect bone integrity and reduce complications associated with cancer spread to bones.

🔬 Mechanism of Action

Zoledronic Acid binds to bone mineral and inhibits osteoclast activity, slowing bone breakdown. This helps:

• Reduce bone pain
• Lower the risk of fractures
• Prevent spinal cord compression
• Control tumor-induced hypercalcemia

💊 Indications

Zoltero 4 mg is prescribed for:

• Bone metastases from solid tumors (including breast, prostate, and lung cancer)
• Multiple Myeloma
• Hypercalcemia of malignancy (HCM)
• Prevention of skeletal-related events in advanced cancers

📌 Key Features of Zoltero 4 mg

• Strength: 4 mg
• Dosage Form: Intravenous infusion
• Therapeutic Class: Bisphosphonate
• Administration: Given as IV infusion over at least 15 minutes by healthcare professionals
• Monitoring: Kidney function tests and serum calcium levels required before each dose

⚕️ Benefits of Zoltero 4 mg

• Reduces skeletal complications in cancer patients
• Helps maintain bone strength
• Controls high calcium levels effectively
• Long duration of action

⚠️ Precautions

• Renal function must be assessed before administration
• Ensure adequate hydration prior to infusion
• Risk of hypocalcemia; calcium and vitamin D supplementation may be required
• Rare risk of osteonecrosis of the jaw (ONJ) — dental evaluation recommended before treatment

Zoltero 4 mg (Zoledronic Acid Injection) is an essential supportive oncology therapy designed to protect bone health, reduce complications, and improve quality of life in patients with advanced cancers affecting the skeletal system.